---
title: "Sanofi India Ltd (SANOFI) — Share Price, Financials & Analysis"
symbol: "SANOFI"
company: "Sanofi India Ltd"
canonical: "https://tapetide.com/stocks/SANOFI"
isin: "INE058A01010"
nse_symbol: "SANOFI"
bse_code: "500674"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 7112.09
generated_at: "2026-09-13T19:58:58.978Z"
---

# Sanofi India Ltd (SANOFI)

Canonical page: https://tapetide.com/stocks/SANOFI

## Company

- **NSE Symbol:** SANOFI
- **BSE Code:** 500674
- **ISIN:** INE058A01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2003-05-19
- **CEO:** Mr. Rachid Ayari
- **Employees:** 1225
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sanofiindialtd.com

## About

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

## Latest Price

- **Price:** ₹3079.2
- **Change:** -26.8 (-0.86%)
- **Open:** ₹3101.3
- **Day High:** ₹3105.4
- **Day Low:** ₹3069.3
- **Previous Close:** ₹3106
- **Volume:** 9890
- **As Of:** 2026-09-11T09:59:55+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:57.559423Z.

- **Market Cap:** ₹7112.09 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.1
- **P/E (TTM):** 21.87
- **EPS (TTM):** ₹140.78
- **EPS (reported):** ₹213.31
- **Book Value:** ₹358.68
- **Price to Book:** 8.66
- **Dividend Yield:** 2.41%
- **ROE:** 36.45%
- **ROCE:** 48.5%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹2029.7 Cr
- **Net Income:** ₹313.7 Cr
- **EBITDA:** ₹507.3 Cr
- **52-Week High:** ₹5113.5
- **52-Week Low:** ₹3054
- **RSI (14):** 34.95

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 75.05 | 9% |
| growth | 7.04 | 9% |
| momentum | 18.7 | 12% |
| ownership | 35.55 | 24% |
| quality | 70.75 | 22% |
| valuation | 76.17 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 47.8%
- Company has been maintaining a healthy dividend payout of 71.8%

### Weaknesses

- Stock is trading at 8.57 times its book value
- The company has delivered a poor sales growth of -8.74% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 100.3% | — | — |
| ebitda margin growth | 32.53% | -6.33% | — | — |
| net income growth | 30.89% | -13.96% | -13% | -7% |
| revenue growth | 1.97% | -1.34% | -13% | -9% |
| roce | 35.07% | -2.71% | — | — |
| roe | 30.89% | 1.5% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 491 | 469 | 511 | 464 | 524 | 515 | 536 | 406 | 475 | 420 | 472 | 438 |
| Expenses | 377 | 370 | 374 | 348 | 404 | 397 | 364 | 311 | 341 | 330 | 330 | 322 |
| Operating Profit | 114 | 100 | 137 | 116 | 120 | 118 | 172 | 95 | 134 | 90 | 143 | 115 |
| OPM % | 23 | 21 | 27 | 25 | 23 | 23 | 32 | 23 | 28 | 22 | 30 | 26 |
| Other Income | 82 | 77 | 41 | 21 | 2 | 14 | 3 | 9 | -22 | 3 | 4 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 9 | 9 | 10 | 9 | 9 |
| Profit before tax | 186 | 167 | 169 | 127 | 113 | 122 | 165 | 94 | 102 | 83 | 138 | 112 |
| Tax % | 18 | 18 | 19 | 19 | 27 | 25 | 28 | 26 | 26 | 26 | 26 | 26 |
| Net Profit | 152 | 138 | 137 | 103 | 82 | 91 | 120 | 70 | 76 | 62 | 103 | 84 |
| EPS in Rs | 66.17 | 59.87 | 59.39 | 44.96 | 35.74 | 39.7 | 51.96 | 30.22 | 33.04 | 26.83 | 44.61 | 36.3 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2460 | 2771 | 3071 | 2902 | 2957 | 2770 | 2851 | 2013 | 1837 | 1805 |
| Expenses | 1921 | 2146 | 2403 | 2186 | 2194 | 2066 | 2047 | 1522 | 1346 | 1323 |
| Operating Profit | 538 | 625 | 667 | 716 | 762 | 704 | 804 | 491 | 491 | 483 |
| OPM % | 22 | 23 | 22 | 25 | 26 | 25 | 28 | 24 | 27 | 27 |
| Other Income | 79 | 88 | 33 | 45 | 564 | 204 | 83 | 79 | -8 | -9 |
| Interest | 1 | 1 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 102 | 103 | 100 | 82 | 67 | 42 | 40 | 37 | 37 | 36 |
| Profit before tax | 515 | 610 | 600 | 677 | 1258 | 864 | 846 | 531 | 445 | 436 |
| Tax % | 37 | 38 | 31 | 29 | 25 | 28 | 29 | 22 | 27 | — |
| Net Profit | 326 | 381 | 414 | 478 | 944 | 621 | 603 | 414 | 327 | 324 |
| EPS in Rs | 141.74 | 165.48 | 180.09 | 207.65 | 410.61 | 269.83 | 262.26 | 179.78 | 142.04 | 140.78 |
| Dividend Payout % | 50 | 51 | 194 | 176 | 119 | 211 | 64 | 65 | 87 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 2003 | 2196 | 2419 | 2096 | 2203 | 1253 | 992 | 838 | 726 | 803 |
| Borrowings | 0 | 0 | 0 | 23 | 25 | 24 | 19 | 19 | 18 | 15 |
| Other Liabilities | 751 | 765 | 802 | 777 | 811 | 772 | 681 | 732 | 488 | 567 |
| Total Liabilities | 2778 | 2984 | 3244 | 2918 | 3061 | 2072 | 1715 | 1612 | 1255 | 1407 |
| Fixed Assets | 769 | 733 | 499 | 464 | 334 | 306 | 315 | 312 | 304 | 291 |
| CWIP | 30 | 21 | 17 | 10 | 13 | 24 | 16 | 18 | 12 | 19 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Other Assets | 1978 | 2230 | 2728 | 2444 | 2714 | 1743 | 1382 | 1281 | 939 | 1098 |
| Total Assets | 2778 | 2984 | 3244 | 2918 | 3061 | 2072 | 1715 | 1612 | 1255 | 1407 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 322 | 435 | 374 | 412 | 611 | 559 | 399 | 231 | 462 | 438 |
| Cash from Investing Activity | -155 | -79 | -73 | 66 | 276 | 631 | 651 | 36 | -178 | -11 |
| Cash from Financing Activity | -180 | -188 | -197 | -183 | -810 | -849 | -1583 | -878 | -392 | -448 |
| Net Cash Flow | -13 | 168 | 104 | 295 | 78 | 341 | -533 | -612 | -109 | -21 |
| Free Cash Flow | 253 | 379 | 317 | 337 | 810 | 574 | 412 | 221 | 426 | 413 |
| CFO/OP | 101 | 118 | 99 | 96 | 112 | 111 | 94 | 59 | 114 | 111 |

### Ratios

| Item | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 22 | 29 | 21 | 27 | 19 | 18 | 17 | 17 | 42 | 35 |
| Inventory Days | 169 | 151 | 154 | 127 | 107 | 110 | 125 | 202 | 186 | 127 |
| Days Payable | 79 | 119 | 110 | 100 | 93 | 105 | 109 | 89 | 151 | 79 |
| Cash Conversion Cycle | 112 | 61 | 65 | 54 | 33 | 22 | 33 | 130 | 77 | 83 |
| Working Capital Days | 79 | 17 | 18 | 35 | -8 | -20 | -19 | 24 | 17 | 7 |
| ROCE % | 27 | 26 | 29 | 28 | 32 | 35 | 41 | 71 | 49 | 58 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% | 60.4% |
| FIIs | 6.8% | 6.31% | 6.11% | 5.81% | 5.78% | 5.63% | 5.57% | 5.61% | 5.57% | 5.55% | 5.64% | 5.69% |
| DIIs | 21.69% | 22.47% | 23.08% | 22.79% | 22.82% | 22.93% | 23.02% | 23.06% | 22.29% | 21.31% | 21.13% | 19.86% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 8.6% | 8.09% | 7.97% | 8.31% | 8.21% | 8.33% | 8.38% | 8.33% | 9.08% | 10.02% | 10.19% | 11.38% |
| Others | 2.51% | 2.73% | 2.44% | 2.69% | 2.79% | 2.7% | 2.63% | 2.61% | 2.67% | 2.73% | 2.64% | 2.67% |
| No. of Shareholders | 68598 | 62870 | 61849 | 67662 | 66211 | 66401 | 68196 | 66790 | 71395 | 75813 | 75758 | 80005 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 3131.17 | Sell |
| EMA (10) | 3132.98 | Sell |
| SMA (20) | 3186.14 | Sell |
| EMA (20) | 3177.31 | Sell |
| SMA (50) | 3293.06 | Sell |
| EMA (50) | 3252.16 | Sell |
| SMA (100) | 3294.01 | Sell |
| EMA (100) | 3362.01 | Sell |
| SMA (200) | 3610.98 | Sell |
| EMA (200) | 3714.72 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 32.44 | Neutral |
| MACD (12,26,9) | -55.48 | Sell |
| Stochastic (14,3,3) | 3.37 | Buy |
| ADX (14) | 28.95 | Buy |
| Williams %R (14) | -95.24 | Buy |
| ATR (14) | 54.23 | Neutral |
| ROC (12) | -3.51 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 30.79 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 2 | 66.67% |
| Hold | 1 | 33.33% |
| Sell | 0 | 0% |

Based on 3 analyst ratings, observed at 2026-09-11T04:36:00.070074+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad3e1f2e-ff3f-4609-8160-beb77241918f.pdf) |
| 2026-08-31 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Show Cause Notice From GST Authorities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=575001d6-3b82-4def-9669-afb72880ae73.pdf) |
| 2026-08-13 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c4a0c23-755a-4ce1-9d54-2f7dc54261b6.pdf) |
| 2026-08-11 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af98add5-8ac2-4435-b992-69bacb8b3064.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=279acb5e-8966-4398-ab57-4f09be4a18ec.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdc5b4f-69bf-4037-9bd7-ece0c47d6b0f.pdf) |
| 2026-08-04 | [Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1712894c-d7db-4e26-aa18-6128fe963e0d.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b183be56-c887-4e8b-b587-3f92bda1760b.pdf) |
| 2026-08-04 | [Re-Constitution Of The Committees Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca7f685-2dee-4525-be08-4e29a1bcd59c.pdf) |
| 2026-08-04 | [Intimation Under Regulation 30(5) Of The Listing Regulations](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d287442d-1a16-4408-9ed4-decb7d8a9334.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54b814ce-1d61-40ad-b484-4f0246ea1395.pdf) |
| 2026-03-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=950c053c-2b83-44e8-be44-0f7868ebd375.pdf) |
| 2025-11-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e5d2049-34a1-4a06-8779-4054c033ef03.pdf) |
| 2024-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1e0c8f7-2e5f-4830-8ee5-7fc2811f8190.pdf) |
| 2024-02-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a725dff-76b8-4df5-bea8-bb466b860b57.pdf) |
| 2023-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6e335cf-b33d-4d64-b322-cb7ff486a969.pdf) |
| 2023-05-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df63d087-4299-43df-ac77-14fbcd8d27d6.pdf) |
| 2023-02-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29cdf985-5415-4609-acbb-40d50d93b122.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28667e98-8c00-4254-ab39-b5768c412089.pdf) |
| 2026-02-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8349d6b7-eb1e-4dca-82c9-a1846ddd6044.pdf) |
| 2025-10-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27dc448a-dc8f-47e7-aa83-200527fa6db0.pdf) |
| 2024-05-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d03af05-29e0-458a-b6d9-746ebd5a6766.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-04 | [Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87ac29f8-5506-4781-9152-d0f68d337f52.pdf) |
| 2026-04-28 | [Results For The Quarter Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4be4bf50-acdb-4ed5-afd2-8bb846e95a99.pdf) |
| 2026-02-25 | [Results For The Year Ended Dec 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfe21e4d-7064-4338-bcda-4d57f8985685.pdf) |
| 2025-10-29 | [Financial Results For The Quarter And Nine Months Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e64bc382-8049-42f0-9aa8-730194060d93.pdf) |
| 2025-07-31 | [Financial Results For The Quarter And Half-Year Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75f70919-b201-428e-916f-d3d31e1bf383.pdf) |
| 2025-05-14 | [Financials Results For The Quarter Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de753ee-0569-43a3-92bc-0faf3a535d80.pdf) |
| 2025-02-27 | [Financial Results For The Financial Year Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f27a26b-c33f-446c-b0da-362c04996a40.pdf) |
| 2024-11-07 | [Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e28945-1848-44d4-af36-fdc814284cb4.pdf) |
| 2024-07-26 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08844f71-d8ea-49a9-bf89-c5154d29c096.pdf) |
| 2024-05-13 | [Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 31St March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a0d39e0-3fe8-492b-b568-de5c8faf8606.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - CGST authority granted Rs. 52.08 lakh refund, rejected Rs. 11.63 lakh; company will appeal. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015-Refund Order 9h - CGST authority granted Rs. 52.08 lakh refund, rejected Rs. 11.63 lakh; company will appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1af95b12-0ba0-4bde-99b9-3feae6008fb0.pdf) |
| 9 Apr - RTA confirmed Regulation 74(5) compliance for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - RTA confirmed Regulation 74(5) compliance for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c8e8f289-97fe-4f0f-a382-beb583efcbca.pdf) |
| 8h - Sanofi India approved quarter ended 31 March 2026 results; Rahul Bhatnagar appointed Board Chairman from 30 April 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 8h - Sanofi India approved quarter ended 31 March 2026 results; Rahul Bhatnagar appointed Board Chairman from 30 April 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5fb50b20-4b8f-42e6-89b8-2e8f9ff93c77.pdf) |
| 8h - Sanofi India approved Q4 FY26 results on 28 April 2026; Rahul Bhatnagar named Board Chairman. | [Board Meeting Outcome for Of The Board Meeting Of The Company 8h - Sanofi India approved Q4 FY26 results on 28 April 2026; Rahul Bhatnagar named Board Chairman.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a7cc918e-9a67-495a-bb3e-8d8e83972c28.pdf) |
| 8h - Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, the officials of the Company will hold meetings with an Analyst/ … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8h - Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, the officials of the Company will hold meetings with an Analyst/ …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4d10b945-3c06-4ee3-bbf6-586272f6214a.pdf) |
| 7h - Trading window closed from 1 Apr 2026 until 48 hours after quarter-ended 31 Mar 2026 results. | [Closure of Trading Window 7h - Trading window closed from 1 Apr 2026 until 48 hours after quarter-ended 31 Mar 2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a99c9fb8-b13d-46b3-bf87-4240c930b135.pdf) |
| 5 Mar - Transcript of Investor/ Analysts call held on 26th February 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 5 Mar - Transcript of Investor/ Analysts call held on 26th February 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/950c053c-2b83-44e8-be44-0f7868ebd375.pdf) |
| 30 Apr - Rahul Bhatnagar appointed Chairman of Sanofi India Board effective 30 April 2026; Aditya Narayan steps down. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Rahul Bhatnagar appointed Chairman of Sanofi India Board effective 30 April 2026; Aditya Narayan steps down.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aa72adf3-9cea-42d8-acd6-3714f5d1895f.pdf) |
| 30 Apr - Rahul Bhatnagar appointed Chairman of Sanofi India Board effective 30 April 2026; Aditya Narayan steps down. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - Rahul Bhatnagar appointed Chairman of Sanofi India Board effective 30 April 2026; Aditya Narayan steps down.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/aa72adf3-9cea-42d8-acd6-3714f5d1895f.pdf) |
| 29 Apr - Copies of the Newspaper Publication of Financial Results for quarter ended 31st March 2026, as published in Business Standard (English) and Sakal (Marathi) today i.e. … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Copies of the Newspaper Publication of Financial Results for quarter ended 31st March 2026, as published in Business Standard (English) and Sakal (Marathi) today i.e. …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ddc51269-98ac-4a91-920b-1c9ee025513e.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-02-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2adabe4a-de15-4dbd-88c5-38042f596c98.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e5d2049-34a1-4a06-8779-4054c033ef03.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4053f94-a1ff-4d69-b7f1-df5e63291e0b.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4053f94-a1ff-4d69-b7f1-df5e63291e0b.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6e335cf-b33d-4d64-b322-cb7ff486a969.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1e0c8f7-2e5f-4830-8ee5-7fc2811f8190.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=039c765f-b042-49f7-9b78-88d95fc8ae2b.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/039c765f-b042-49f7-9b78-88d95fc8ae2b.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/df63d087-4299-43df-ac77-14fbcd8d27d6.pdf) |
| Mar 2021 | [Concall - Mar 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78119a4a-e60b-472a-972c-14ec75cb6f5f.pdf) |
| Mar 2021 | [Concall - Mar 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78119a4a-e60b-472a-972c-14ec75cb6f5f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3226_SANOFI_2013_2013_28032014132857.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5388e656-d14d-4d10-8673-6fd2c8a15779.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6b7790a9-23d6-4917-af68-bc15d1160624.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/32aeea19-d29c-4a60-9397-0c1578965bb1.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bae3c01d-d946-4000-bc1a-af7ea2c945ea.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500674/72957500674.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500674/68387500674.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500674/5006741219.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500674/5006741218.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/500674/5006741217.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:58:58.978Z.